Biopharmaceuticals has embarked on the fast lane of technological iteration because of the prevalence of tumor immunotherapy and monoclonal antibody drugs. In the pursuit of capacity upgrading, the company has been striving for excellence in product biological activity and process optimization, as well as the degree of specialization in all aspects of the industrial chain. Higher requirements were raised.
Genetime Excell Bio has a comprehensive line of cells, molecules and immunological products, which can provide high-quality imported fetal bovine serum, serum-free medium and other cell culture core reagents and related products for the biopharmaceutical industry; and qPCR Mix, ELISA detection A tool for the detection and identification of transcription and translation in kits.